PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis

被引:107
作者
Bilak, M
Wu, LJ
Wang, Q
Haughey, N
Conant, K
Hillaire, CS
Andreasson, K
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
关键词
D O I
10.1002/ana.20179
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent studies suggest that the inducible isoform of cyclooxygenase, COX-2, promotes motor neuron loss in rodent models of AM. We investigated the effects of PGE(2), a principal downstream prostaglandin product of COX-2 activity, on motor neuron survival in an organotypic culture model of ALS. We find that PGE2 paradoxically protects motor neurons at physiological concentrations in this model. PGE(2) exerts its downstream effects by signaling through a class of four distinct G-protein-coupled E-prostanoid receptors (EP1-EP4) that have divergent effects on cAMP. EP2 and EP3 are dominantly expressed in ventral spinal cord in neurons and astrocytes, and activation of these receptor subtypes individually or in combination also rescued motor neurons. The EP2 receptor is positively coupled to cAMP, and its neuroprotection was mimicked by application of forskolin and blocked by inhibition of PKA, suggesting that its protective effect is mediated by downstream effects of cAMP. Conversely, the EP3 receptor is negatively coupled to cAMP, and its neuroprotective effect was blocked by pertussis toxin, suggesting that its protective effect is dependent on Gi-coupled heterotrimeric signaling. Taken together, these data demonstrate an unexpected neuroprotective effect mediated by PGE(2), in which activation of its EP2 and EP3 receptors protected motor neurons from chronic glutamate toxicity.
引用
收藏
页码:240 / 248
页数:9
相关论文
共 69 条
  • [1] Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis
    Almer, G
    Vukosavic, S
    Romero, N
    Przedborski, S
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (06) : 2415 - 2425
  • [2] Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients
    Almer, G
    Teismann, P
    Stevic, Z
    Halaschek-Wiener, J
    Deecke, L
    Kostic, V
    Przedborski, S
    [J]. NEUROLOGY, 2002, 58 (08) : 1277 - 1279
  • [3] Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO
  • [4] 2-O
  • [5] Anderson CM, 2001, J NEUROCHEM, V79, P1207
  • [6] Andreasson KI, 2001, J NEUROSCI, V21, P8198
  • [7] A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS
    BENSIMON, G
    LACOMBLEZ, L
    MEININGER, V
    BOUCHE, P
    DELWAIDE, C
    COURATIER, P
    BLIN, O
    VIADER, F
    PEYROSTPAUL, H
    DAVID, J
    MALOTEAUX, JM
    HUGON, J
    LATERRE, EC
    RASCOL, A
    CLANET, M
    VALLAT, JM
    DUMAS, A
    SERRATRICE, G
    LECHEVALLIER, B
    PEUCH, AJ
    NGUYEN, T
    SHU, C
    BASTIEN, P
    PAPILLON, C
    DURRLEMAN, S
    LOUVEL, E
    GUILLET, P
    LEDOUX, L
    ORVOENFRIJA, E
    DIB, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) : 585 - 591
  • [8] Bilak MM, 2001, AMYOTROPH LATERAL SC, V2, P83
  • [9] Neuroprotective utility and neurotrophic action of neurturin in postnatal motor neurons: Comparison with GDNF and persephin
    Bilak, MM
    Shifrin, DA
    Corse, AM
    Bilak, SR
    Kuncl, RW
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 1999, 13 (05) : 326 - 336
  • [10] Bilak MM, 2002, J NEUROSCI, V22, P9378